tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Expleo Solutions Discloses ITAT Order on ₹25.38 Crore Tax Demand for FY 2021–22

Story Highlights
  • Expleo Solutions has reported an ITAT Chennai order on its 2021–22 tax assessment involving major disallowances.
  • Tax adjustments totaling about ₹25.38 crore highlight scrutiny of Expleo’s intra-group payments and may affect its financials.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Expleo Solutions Discloses ITAT Order on ₹25.38 Crore Tax Demand for FY 2021–22

Claim 50% Off TipRanks Premium

Expleo Solutions Limited ( (IN:EXPLEOSOL) ) has issued an update.

Expleo Solutions Limited has disclosed that the Income Tax Appellate Tribunal ‘D’ Bench in Chennai has issued an order concerning the company’s assessment for the financial year 2021–22, following earlier proceedings before the Assessing Officer and the Dispute Resolution Panel. The case involves significant tax adjustments related to disallowances on service and reimbursement costs paid to subsidiaries and group companies, as well as additions arising from TDS reconciliation differences and interest on trade receivables, leading to a total tax demand of Rs. 25.38 crore, of which the company has already deposited 20 percent; the outcome underscores ongoing tax scrutiny over intra-group transactions and could have implications for Expleo’s financials and compliance posture depending on final resolution of the dispute.

More about Expleo Solutions Limited

Expleo Solutions Limited is an India-based company listed on both BSE and NSE, operating in the technology and professional services space, with a focus on providing IT and engineering-related solutions to clients. The company serves domestic and international markets, leveraging group and subsidiary networks for service delivery and cost-sharing arrangements.

Average Trading Volume: 888

Technical Sentiment Signal: Sell

Current Market Cap: 14.08B INR

For a thorough assessment of EXPLEOSOL stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1